A detailed history of Keynote Financial Services LLC transactions in Citius Pharmaceuticals, Inc. stock. As of the latest transaction made, Keynote Financial Services LLC holds 17,500 shares of CTXR stock, worth $54,775. This represents 0.01% of its overall portfolio holdings.

Number of Shares
17,500
Previous 17,500 -0.0%
Holding current value
$54,775
Previous $10.2 Million 14.23%
% of portfolio
0.01%
Previous 0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Jun 13, 2024

BUY
$0.6 - $0.9 $10,500 - $15,750
17,500 New
17,500 $15.7 Million

Others Institutions Holding CTXR

About Citius Pharmaceuticals, Inc.


  • Ticker CTXR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 146,130,000
  • Market Cap $457M
  • Description
  • Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...
More about CTXR
Track This Portfolio

Track Keynote Financial Services LLC Portfolio

Follow Keynote Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keynote Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keynote Financial Services LLC with notifications on news.